IGSF8 is an innate immune checkpoint and cancer immunotherapy target

Post time 2024-4-25 10:05:53

journal：Cell

Authors：Yulong Li; Xiangyang Wu; Caibin Sheng; Hailing Liu; Huizhu Liu; Yixuan Tang; Chao Liu; Qingyang Ding; Bin Xie; Xi Xiao; Rongbin Zheng; Quan Yu; Zengdan Guo; Jian Ma; Jin Wang; Jinghong Gao; Mei Tian; Wei Wang; Jia Zhou; Li Jiang; Mengmeng Gu; Sailing Shi; Michael Paull; Guanhua Yang; Wei Yang; Steve Landau; Xingfeng Bao; Xihao Hu; X. Shirley Liu; Tengfei Xiao

Published date：2024-4-

DOI：10.1016/j.cell.2024.03.039

PDF link：https://www.sciencedirect.com/sc ... 092867424003556/pdf

Article link：http://dx.doi.org/10.1016/j.cell.2024.03.039

Article Source：Elsevier BV。

Remark：

Post time 2024-4-25 10:05:54

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] IGSF8 is an innate immune checkpoint and cancer immunotherapy target

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] IGSF8 is an innate immune checkpoint and cancer immunotherapy target Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] IGSF8 is an innate immune checkpoint and cancer immunotherapy target